Trial Profile
The Thorough QT/QTc Study of TS-071 in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Jan 2022
Price :
$35
*
At a glance
- Drugs Luseogliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Taisho Pharmaceutical
- 09 Jun 2016 New trial record